Review article · 2008 · Open access

Immunological features of α‐synuclein in Parkinson's disease

Cintia Roodveldt, John Christodoulou, Christopher Martin Dobson

Journal of Cellular and Molecular Medicine, 12(5b), 1820–1829 · Published 30 July 2008 · DOI 10.1111/j.1582-4934.2008.00450.x

Open PDFView at the publisherCite this paper

In brief

“Immunological features of α‐synuclein in Parkinson's disease” is a 2008 review article by Cintia Roodveldt and 2 co-authors, published in Journal of Cellular and Molecular Medicine. OpenAlex counts 106 citations as of 18 November 2026. It is open access: the full text is free to read at PubMed Central.

Citations
106
Most cited in
2023 (7)
Field-weighted impact
1.32
References
117
Authors
3

Abstract

Introduction Importance of inflammation processes in PD pathology Stimulation of microglia by αSyn αSyn‐triggered stimulation of the innate immune system Other proteins up‐regulated by αSyn‐triggered microglial activation αSyn and apoptosis of immune cells Links between αSyn and astrocytes or oligodendrocytes αSyn and the humoural immune system in PD Expression of αSyn in immunocompetent cells Prospects for αSyn‐ and immune‐based therapeutic approaches in PD Concluding remarks Abstract Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized pathologically by the presence, in the brain, of intra‐cellular protein inclusions highly enriched in aggregated α‐synuclein (αSyn), known as Lewy bodies. The onset of PD is accompanied by a local immune reaction in regions of the brain affected by the inclusions, although the mechanism that leads to pathogenesis is far from clear. It is, however, established that disease onset and progression are characterized by sustained activation of microglia, which is linked to significant dopaminergic neuron loss in the substantia nigra. A recent body of evidence indicates that aggregated or modified αSyn can indeed trigger the activation of microglia, inducing a lethal cascade of neuroinflammation and eventually, neuronal loss, pointing at aggregated and modified forms of αSyn as a primary cause of PD pathogenesis. By releasing toxic factors, or by phagocy‐tosing neighbouring cells, activated microglia and astrocytes may form a self‐perpetuating cycle for neuronal degeneration. Additional findings suggest a link between αSyn and humoural‐mediated mechanisms in PD. In this review, we attempt to recapitulate our current understanding of PD physiopathology focused on αSyn and its links with the immune system, as well as of novel and promising therapeutic avenues for the treatment of PD and of other synucleinopathies.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Roodveldt, C., Christodoulou, J., & Dobson, C. M. (2008). Immunological features of α‐synuclein in Parkinson's disease. Journal of Cellular and Molecular Medicine, 12(5b), 1820–1829. https://doi.org/10.1111/j.1582-4934.2008.00450.x

MLA 9

Roodveldt, Cintia, et al. “Immunological features of α‐synuclein in Parkinson's disease.” Journal of Cellular and Molecular Medicine, vol. 12, no. 5b, 2008, pp. 1820–1829. https://doi.org/10.1111/j.1582-4934.2008.00450.x.

Chicago

Roodveldt, Cintia, John Christodoulou, and Christopher Martin Dobson. 2008. “Immunological features of α‐synuclein in Parkinson's disease.” Journal of Cellular and Molecular Medicine 12 (5b): 1820–1829. https://doi.org/10.1111/j.1582-4934.2008.00450.x.

Harvard

Roodveldt, C., Christodoulou, J. and Dobson, C. M. (2008) ‘Immunological features of α‐synuclein in Parkinson's disease’, Journal of Cellular and Molecular Medicine, 12(5b), pp. 1820–1829. doi:10.1111/j.1582-4934.2008.00450.x.

IEEE

C. Roodveldt, J. Christodoulou, and C. M. Dobson, “Immunological features of α‐synuclein in Parkinson's disease,” Journal of Cellular and Molecular Medicine, vol. 12, no. 5b, pp. 1820–1829, 2008, doi: 10.1111/j.1582-4934.2008.00450.x.

BibTeX

@article{roodveldt2008immunological,
  title     = {{Immunological features of α‐synuclein in Parkinson's disease}},
  author    = {Roodveldt, Cintia and Christodoulou, John and Dobson, Christopher Martin},
  journal   = {Journal of Cellular and Molecular Medicine},
  year      = {2008},
  volume    = {12},
  number    = {5b},
  pages     = {1820--1829},
  doi       = {10.1111/j.1582-4934.2008.00450.x},
  url       = {https://doi.org/10.1111/j.1582-4934.2008.00450.x}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201755
201822
201911
202066
202133
202244
202377
202411
202511
202633

Its field-weighted citation impact is 1.32: it has been cited 1.32 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments

  • Parkinson's disease
  • alpha-synuclein
  • neuroinflammation
  • microglial activation
  • Lewy bodies
  • astrocytes
  • oligodendrocytes
  • apoptosis

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Roodveldt, C., Christodoulou, J., & Dobson, C. M. (2008). Immunological features of α‐synuclein in Parkinson's disease. Journal of Cellular and Molecular Medicine, 12(5b), 1820–1829. https://doi.org/10.1111/j.1582-4934.2008.00450.x

How many times has this paper been cited?

106 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PubMed Central: sign in and open the PDF from this page.

Who wrote this paper?

Cintia Roodveldt, John Christodoulou, Christopher Martin Dobson.

What is the DOI of this paper?

10.1111/j.1582-4934.2008.00450.x, permanently at https://doi.org/10.1111/j.1582-4934.2008.00450.x. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.